# SpyGlass Pharma, Inc.: filings

SGP · Nasdaq · CIK 1778922 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sgp.md) · [Financials](/companies/sgp/financials.md) · [Filings](/companies/sgp/filings.md) · [Insiders](/companies/sgp/insiders.md)

## Reports and events: 17 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 29, 3 24, 8-K 8, CORRESP 4, D 4, SCHEDULE 13D 4, UPLOAD 3, 10-Q 2, SCHEDULE 13G 2, 10-K 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, EFFECT 1, S-1 1, S-1/A 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:10 ET | [8-K](/filings/0001778922-26-000052.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001778922-26-000052 |
| 2026-10-01 | 12:15 ET | [8-K](/filings/0001778922-26-000049.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001778922-26-000049 |
| 2026-08-06 | 20:37 ET | [10-Q](/filings/0001778922-26-000045.md) | Quarterly report, period 2026-06-30 | 0001778922-26-000045 |
| 2026-08-06 | 20:16 ET | [8-K](/filings/0001778922-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001778922-26-000044 |
| 2026-05-14 | 20:30 ET | [10-Q](/filings/0001778922-26-000035.md) | Quarterly report, period 2026-03-31 | 0001778922-26-000035 |
| 2026-05-14 | 20:15 ET | [8-K](/filings/0001778922-26-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001778922-26-000033 |
| 2026-03-26 | 21:23 ET | [10-K](/filings/0001778922-26-000020.md) | Annual report, period 2025-12-31 | 0001778922-26-000020 |
| 2026-03-26 | 20:06 ET | [8-K](/filings/0001778922-26-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001778922-26-000018 |
| 2026-03-09 | 20:05 ET | [8-K](/filings/0001778922-26-000004.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001778922-26-000004 |
| 2026-02-17 | 00:21 ET | [SCHEDULE 13D](/filings/0001346824-26-000061.md) | Ownership report, active investor | 0001346824-26-000061 |
| 2026-02-13 | 23:21 ET | [SCHEDULE 13D](/filings/0001072613-26-000183.md) | Ownership report, active investor | 0001072613-26-000183 |
| 2026-02-13 | 21:05 ET | [SCHEDULE 13D](/filings/0001193125-26-051323.md) | Ownership report, active investor | 0001193125-26-051323 |
| 2026-02-13 | 21:01 ET | [8-K](/filings/0001628280-26-008073.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-008073 |
| 2026-02-10 | 23:29 ET | [SCHEDULE 13D](/filings/0001193125-26-045048.md) | Ownership report, active investor | 0001193125-26-045048 |
| 2026-02-09 | 21:22 ET | [8-K](/filings/0001628280-26-006460.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-006460 |
| 2026-01-29 | 20:05 ET | [S-1/A](/filings/0001628280-26-004091.md) | Registration statement, amended | 0001628280-26-004091 |
| 2026-01-16 | 20:10 ET | [S-1](/filings/0001628280-26-002356.md) | Registration statement | 0001628280-26-002356 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.